Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Amneal Pharmaceuticals A | AMRX | Aug 30, 2024 | 8.66 | -0.12 |
Ampco-Pittsburgh | AP | Aug 30, 2024 | 2.03 | +2.01 |
Amphastar Pharmaceuticals | AMPH | Aug 30, 2024 | 48.74 | -0.25 |
Amphenol | APH | Aug 30, 2024 | 67.45 | +0.99 |
Amplify Energy | AMPY | Aug 30, 2024 | 7.13 | -0.70 |
Amplify Online Retail ETF | IBUY | Aug 30, 2024 | 56.24 | +0.71 |
Amplify Transformational Data Sharing ETF | BLOK | Aug 30, 2024 | 35.37 | +0.34 |
Amplitech Group | AMPG | Aug 30, 2024 | 0.83 | +23.71 |
Amplitude A | AMPL | Aug 30, 2024 | 8.81 | -1.89 |
Amprius Technologies | AMPX | Aug 30, 2024 | 1.07 | -3.60 |
AMREP | AXR | Aug 30, 2024 | 21.75 | -0.28 |
AMTD Digital ADR | HKD | Aug 30, 2024 | 2.97 | +2.77 |
AMTD Idea Group ADR | AMTD | Aug 30, 2024 | 1.29 | -5.15 |
Amtech Systems | ASYS | Aug 30, 2024 | 6.36 | +1.60 |
Amylyx Pharmaceuticals | AMLX | Aug 30, 2024 | 2.22 | +4.72 |
AN2 Therapeutics | ANTX | Aug 30, 2024 | 1.13 | 0.00 |
Analog Devices | ADI | Aug 30, 2024 | 234.84 | +1.71 |
AnaptysBio | ANAB | Aug 30, 2024 | 38.09 | +4.01 |
Anavex Life Sciences | AVXL | Aug 30, 2024 | 6.02 | +0.84 |
Anebulo Pharmaceuticals | ANEB | Aug 30, 2024 | 1.92 | +5.14 |
ANEW Medical | WENA | Aug 30, 2024 | 0.93 | 0.00 |
Angel Oak Financial Strategies | FINS | Aug 30, 2024 | 12.82 | +0.20 |
Angel Oak Mortgage REIT | AOMR | Aug 30, 2024 | 11.30 | -0.44 |
Anghami | ANGH | Aug 30, 2024 | 0.88 | +0.01 |
Angi A | ANGI | Aug 30, 2024 | 2.70 | +1.50 |
AngioDynamics | ANGO | Aug 30, 2024 | 7.46 | 0.00 |
Anglogold Ashanti | AU | Aug 30, 2024 | 29.67 | -2.82 |
Anheuser-Busch InBev ADR | BUD | Aug 30, 2024 | 61.44 | -0.13 |
ANI Pharmaceuticals | ANIP | Aug 30, 2024 | 63.75 | +2.08 |
Anika Therapeutics | ANIK | Aug 30, 2024 | 25.70 | +0.27 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.